Table 3 Agreement with statements on the components of screening at birth and in childhood in rounds 1 and 2
From: A modified Delphi study of screening for fetal alcohol spectrum disorders in Australia
Statement | R1 N | R1 % Agree†(IQD) | R2 % Agree†(IQD) |
|---|---|---|---|
Screening at birth | |||
1. prenatal alcohol exposure | 92 | 98 (1) | - |
2. birth weight, length and head circumference | 90 | 100 (1) | - |
3. fatty acid esters (FAEE) in meconium collected within 72 hours of birth | 37 | 46 (3) | - |
4. characteristic FAS facial anomalies | 89 | 98 (1) | - |
5. birth defects | 89 | 98 (1) | - |
6. evidence of withdrawal from alcohol or other drugs | 90 | 99 (1) | - |
7. family history of FASD or developmental delay | 79 | - | 95 (1) |
8. evidence of CNS dysfunction including irritability, feeding difficulties or other neurological signs | 77 | 91 (1) | |
9. most of the information required for FASD screening at birth is routinely collected at birth | 72 | - | 56 (2) |
10. screening for FASD at birth primarily requires health professionals to assess prenatal alcohol exposure and consider it as a potential cause of other relevant abnormalities identified | 79 | - | 86 (1) |
11. a checklist is needed to support the implementation of screening for FASD at birth that identifies the components to be assessed and criteria for conducting a full diagnostic evaluation | 79 | - | 84 (1) |
Screening in childhood | |||
12. prenatal alcohol exposure | 90 | 97 (1) | - |
13. growth (height and weight) | 89 | 98 (1) | - |
14. head circumference | 86 | 99 (1) | - |
15. developmental delay | 89 | 99 (1) | - |
16. neurological signs | 87 | 93 (1) | - |
17. functional CNS abnormalities (e.g. cognition, behaviour disorders) | 88 | 99 (1) | - |
18.hearing and vision | 85 | 93 (1) | - |
19. characteristic FAS facial anomalies | 89 | 98 (1) | - |
20. birth defects | 89 | 97 (1) | - |
21. family history of FASD, developmental delay, abuse or neglect | 78 | - | 97 (1) |
22. most of the information required for FASD screening in childhood is routinely assessed as part of a general clinical assessment of children with neurodevelopmental or other related presentations | 71 | - | 59 (2) |
23. screening for FASD in childhood primarily requires health professionals to assess prenatal alcohol exposure and consider it as a potential cause of other relevant abnormalities identified (e.g. abnormalities of development, learning, behaviour) | 77 | - | 88 (1) |
24. a checklist is needed to support the implementation of screening for FASD in childhood that identifies the components to be assessed and criteria for conducting a full diagnostic evaluation | 78 | - | 90 (1) |